This volume provides a concise yet comprehensive overview of minimal residual disease (MRD)
testing. The text reviews the history of MRD testing MRD testing for acute lymphoblastic
leukemia lymphoma molecular diagnostics for MRD analysis in hematopoietic malignancies the
use of difference from normal flow cytometry in monitoring AML response ML-DS for measurable
residual disease detection and advancements in next generation sequencing for detecting MRD.
Written by experts in the field Minimal Residual Disease Testing: Current Innovations and
Future Directions is a valuable resource for hematologists oncologists pathologists and
radiologists on the variety of technologies available to detect MRD and how best to integrate
these platforms into clinical practice.
